Nicholas B Norgard

Cardiovascular Disease: In‐Depth Look

M. Abu-Fadel, Nicholas B Norgard, Nicholas B. Norgard, 2011 .

Drug–Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors

G. Wall, Nicholas B Norgard, Kathryn D. Mathews, 2009, The Annals of pharmacotherapy.

Cangrelor:anovelP2Y 12 receptor antagonist

Nicholas B Norgard, Nicholas B. Norgard, 2009 .

Cangrelor: a novel P2Y12 receptor antagonist

Nicholas B Norgard, Nicholas B. Norgard, 2009, Expert opinion on investigational drugs.

Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes

J. DiNicolantonio, Nicholas B Norgard, Nicholas B. Norgard, 2013, Postgraduate medicine.

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention

M. Abu-Fadel, Nicholas B Norgard, Nicholas B. Norgard, 2009, Vascular health and risk management.

The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge

A. López-Candales, Nicholas B Norgard, Nicholas B. Norgard, 2021, Postgraduate medicine.

The in vitro effects of niacin on platelet biomarkers in human volunteers

W. Boden, D. Aradi, V. Serebruany, 2010, Thrombosis and Haemostasis.